Trazodone addiction
Pro Research Analysisby 
Searched over 200M research papers for "trazodone addiction"
Trazodone Addiction: Insights from Recent Research
Trazodone and Alcohol Relapse
Trazodone is frequently prescribed to manage sleep disturbances in patients recovering from alcohol dependence. However, its impact on relapse rates has been a subject of investigation. A retrospective study reviewed records of patients discharged from a residential alcohol treatment program and found no significant association between trazodone use at discharge and alcohol relapse rates at six months1. This suggests that while trazodone is commonly used, it may not influence relapse rates significantly.
Trazodone in Treating Psychoactive Substance Addiction
Trazodone, classified as a serotonin antagonist and reuptake inhibitor (SARI), has been studied for its effects on various addictions, including alcohol, benzodiazepines, and opiates. Research indicates that trazodone can be beneficial in treating these addictions, potentially due to its complex mechanism of action and relatively mild side effect profile2. Despite the lack of placebo-controlled studies, the positive outcomes suggest that trazodone could be a valuable component of addiction treatment programs.
Trazodone for Sleep Disorders and Anxiety in Methamphetamine Addicts
A study evaluating trazodone's effectiveness in methamphetamine addicts post-detoxification found that it significantly improved sleep quality and reduced anxiety compared to a placebo. These improvements were observed at the end of the second and fourth weeks of treatment, indicating that trazodone can be effective in managing withdrawal symptoms and preventing relapse in methamphetamine addicts3.
Trazodone's Role in Alcohol and Benzodiazepine Dependency
Trazodone has shown promise in treating depression and sleep disorders in patients with alcohol and benzodiazepine dependencies. Clinical observations suggest that trazodone may improve detoxification outcomes and reduce the risk of developing benzodiazepine dependency. However, the medication is not officially approved for treating these dependencies, and more research is needed to establish comprehensive treatment protocols4.
Trazodone for Sleep Disturbance Post-Alcohol Detoxification
A double-blind, placebo-controlled trial assessed trazodone's efficacy in treating sleep disturbances in alcohol-dependent patients post-detoxification. While trazodone improved sleep quality during the treatment period, it was associated with less improvement in alcohol consumption and increased drinking upon cessation. This finding raises concerns about the routine use of trazodone for sleep disturbances in this population, suggesting that its benefits must be weighed against potential risks5.
Comparative Study: Trazodone vs. Clonidine in Methadone Withdrawal
In a comparative study of trazodone and clonidine for rapid opiate detoxification from methadone, trazodone was found to be as effective as clonidine. Trazodone showed slight superiority in managing some subjective and psychological symptoms without severe adverse effects. This indicates that trazodone is a safe and effective option for acute methadone withdrawal, though further research is needed to explore its long-term efficacy and safety6.
Conclusion
Trazodone has demonstrated potential benefits in treating various substance dependencies, particularly in managing withdrawal symptoms and improving sleep quality. However, its impact on relapse rates and long-term outcomes remains uncertain. While trazodone can be a useful tool in addiction treatment, its use should be carefully considered, and further research is necessary to fully understand its efficacy and safety in different addiction contexts.
Sources and full results
Most relevant research papers on this topic
Trazodone and alcohol relapse: a retrospective study following residential treatment.
Trazodone use during alcoholism treatment does not show a significant association with alcohol relapse rates at 6 months after discharge from residential treatment.
Observational Study[Trazodone in the treatment of addiction].
Trazodone shows a positive effect in treating addiction to psychoactive substances, with promising results and relatively low side effects.
Evaluation of trazodone for treatment of sleep disorders and anxiety in methamphetamine addicts after detoxification
Trazodone effectively improves sleep disorders and reduces anxiety in methamphetamine addicts after detoxification, potentially preventing relapse.
RCT[Pharmacological treatment in alcohol-, drug- and benzodiazepine-dependent patients - the significance of trazodone].
Trazadone shows potential in treating alcohol and benzodiazepine-dependency, potentially improving detoxification and reducing relapse risk.
Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial.
Trazodone may hinder alcohol consumption improvements in the postdetoxification period and lead to increased drinking when stopped, making it unreliable for routine use after detoxification.
RCT
Highly CitedCombined use of trazodone-naltrexone versus clonidine-naltrexone in rapid withdrawal from methadone treatment. A comparative inpatient study.
Trazadone-naltrexone is as effective and well-tolerated as clonidine-naltrexone in rapid opiate detoxification from methadone treatment.
RCTTrazodone in benzodiazepine dependence
Trazadone is a useful alternative anxiolytic in benzodiazepine-dependent patients, reducing anxiety and depressive symptoms without evidence of abuse.
Non-RCTTrazodone for agitation in dementia.
There is insufficient evidence to recommend trazodone as a treatment for behavioral and psychological manifestations of dementia.
Meta-AnalysisHighly CitedA review of the evidence for the efficacy and safety of trazodone in insomnia.
Trazodone's efficacy in treating insomnia is limited and its side effects, such as sedation, dizziness, and psychomotor impairment, raise concerns for its use in nondepressed patients.
Systematic ReviewHighly CitedTrazodone in Sexual Medicine: Underused and Overdosed?
The optimal dose of extended-release Trazodone for hypoactive sexual desire disorder (HSDD) is about 4-20 mg, which may be treated without over-sedation with a dose of 150-mg TRZ matrix tablets or 50-mg IR TRZ tablets.
Literature Review